363 related articles for article (PubMed ID: 23272100)
1. Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population.
Wang S; Diao N; Lu C; Wu J; Gao Y; Chen J; Zhou Z; Huang H; Shao L; Jin J; Weng X; Zhang Y; Zhang W
PLoS One; 2012; 7(12):e51338. PubMed ID: 23272100
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
[TBL] [Abstract][Full Text] [Related]
3. Host biomarkers other than interferon gamma in QFT-TB supernatants for identifying active tuberculosis.
Zhou Y; Zhang F; Shi H; Wu P; Zhou Y
Tuberculosis (Edinb); 2022 Sep; 136():102256. PubMed ID: 36113397
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of IL-2, IL-10, IL-17 and IP-10 as potent discriminative markers for active tuberculosis among pulmonary tuberculosis suspects.
You E; Kim MH; Lee WI; Kang SY
Tuberculosis (Edinb); 2016 Jul; 99():100-108. PubMed ID: 27450011
[TBL] [Abstract][Full Text] [Related]
5. Multiple cytokine analysis based on QuantiFERON-TB gold plus in different tuberculosis infection status: an exploratory study.
Zhang L; Yang Z; Wu F; Ge Q; Zhang Y; Li D; Gao M; Liu X
BMC Infect Dis; 2024 Jan; 24(1):28. PubMed ID: 38166667
[TBL] [Abstract][Full Text] [Related]
6. IL-18/IL-37/IP-10 signalling complex as a potential biomarker for discriminating active and latent TB.
Wawrocki S; Seweryn M; Kielnierowski G; Rudnicka W; Wlodarczyk M; Druszczynska M
PLoS One; 2019; 14(12):e0225556. PubMed ID: 31821340
[TBL] [Abstract][Full Text] [Related]
7. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
8. Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection.
Wu J; Wang S; Lu C; Shao L; Gao Y; Zhou Z; Huang H; Zhang Y; Zhang W
Tuberculosis (Edinb); 2017 Jan; 102():68-75. PubMed ID: 28061954
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
[TBL] [Abstract][Full Text] [Related]
10. Dried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paper.
Aabye MG; Latorre I; Diaz J; Maldonado J; Mialdea I; Eugen-Olsen J; Ravn P; Dominguez J; Ruhwald M
Eur Respir J; 2013 Aug; 42(2):495-503. PubMed ID: 23349445
[TBL] [Abstract][Full Text] [Related]
11. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
Sun Q; Wei W; Sha W
PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
[TBL] [Abstract][Full Text] [Related]
12. Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10.
Ruhwald M; Petersen J; Kofoed K; Nakaoka H; Cuevas LE; Lawson L; Squire SB; Eugen-Olsen J; Ravn P
PLoS One; 2008 Aug; 3(8):e2858. PubMed ID: 18682747
[TBL] [Abstract][Full Text] [Related]
13. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection.
Petrone L; Vanini V; Chiacchio T; Petruccioli E; Cuzzi G; Schininà V; Palmieri F; Ippolito G; Goletti D
Tuberculosis (Edinb); 2018 Jul; 111():147-153. PubMed ID: 30029901
[TBL] [Abstract][Full Text] [Related]
15. Interferon gamma and interferon gamma inducible protein-10 in detecting tuberculosis infection.
Syed Ahamed Kabeer B; Paramasivam P; Raja A
J Infect; 2012 Jun; 64(6):573-9. PubMed ID: 22381458
[TBL] [Abstract][Full Text] [Related]
16. Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study.
Zhang L; Wan S; Zhou Z; Zhang Y; Liu X
BMC Infect Dis; 2021 Jul; 21(1):651. PubMed ID: 34225667
[TBL] [Abstract][Full Text] [Related]
17. Differential T cell responses against DosR-associated antigen Rv2028c in BCG-vaccinated populations with tuberculosis infection.
Zhao HM; Du R; Li CL; Ji P; Li HC; Wu K; Hu Z; Lu SH; Lowrie DB; Fan XY
J Infect; 2019 Apr; 78(4):275-280. PubMed ID: 30528871
[TBL] [Abstract][Full Text] [Related]
18. Alternative biomarkers for classification of latent tuberculosis infection status in pregnant women with borderline Quantiferon plus results.
Tesfaye F; Sturegård E; Walles J; Winqvist N; Balcha TT; Karlson S; Mulleta D; Isberg PE; Jansson M; Björkman P
Tuberculosis (Edinb); 2020 Sep; 124():101984. PubMed ID: 32829076
[TBL] [Abstract][Full Text] [Related]
19. Chemokines additional to IFN-γ can be used to differentiate among Mycobacterium tuberculosis infection possibilities and provide evidence of an early clearance phenotype.
Nonghanphithak D; Reechaipichitkul W; Namwat W; Naranbhai V; Faksri K
Tuberculosis (Edinb); 2017 Jul; 105():28-34. PubMed ID: 28610785
[TBL] [Abstract][Full Text] [Related]
20. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.
Jeong YH; Hur YG; Lee H; Kim S; Cho JE; Chang J; Shin SJ; Lee H; Kang YA; Cho SN; Ha SJ
J Clin Microbiol; 2015 Feb; 53(2):504-10. PubMed ID: 25428147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]